Oncology Market Forecast to 2015: Brand Spending and Development Opportunities

05 Nov 2010 • by Natalie Aster

London - The report “Oncology Market Forecast to 2015: Brand Spending and Development Opportunities ” by Cutting Edge Information allocates brand resources for development and launch. It helps to uncover oncology threats and opportunities, and equips the teams with the most comprehensive forecast of the oncology marketplace.

The study provides following product profile components: product history, sales from 2006 – 2015, competitive and strategic positioning, market growth opportunities, drug’s materiality to company.

Report Details:

Oncology Market Forecast to 2015: Brand Spending and Development Opportunities

Published: January 2010
Pages: 606
 Price: USD 9,995 

Brand Spending Benchmarks Covered:

• Advertising and promotion,
• Medical affairs,
• Decision support (market research),
• Market access,
• Approval history,
• Market exclusivity and patent information (for approved drugs),
• Clinical trial data tables.

Track real brand spending from the pre-clinical period through the first year on the market.

Oncology Drug Manufacturer Profiles Highlighted:

• Amgen,
• AstraZeneca,
• BMS,
• Celgene,
• Eli Lilly,
• Genzyme,
• GSK,
• J&J,
• Merck,
• Novartis,
• Pfizer,
• Roche,
• Sanofi-Aventis.

Explore the industry’s leading oncology portfolios with data on revenues, market share and pipelines in addition to assessments of strengths, growth areas and competition for the companies.

More information can be found in the report “Oncology Market Forecast to 2015: Brand Spending and Development Opportunities ” by Cutting Edge Information .

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
www.marketpublishers.com